Skip to main content

Table 1 Patient demographics

From: Structural effects of sprifermin in knee osteoarthritis: a post-hoc analysis on cartilage and non-cartilaginous tissue alterations in a randomized controlled trial

 

100 μg group

(n = 57)

Matched placebo group

(n = 18)

Age, mean (standard deviation)

61.2 (9.1)

60.9 (6.9)

Sex, no. (%) female

39 (68.4)

12 (66.7)

Body mass index (standard deviation)

30.5 (5.0)

31.5 (5.3)

Kellgren-Lawrence grade 3 (%)

29 (50.9)

11 (61.1)

Time since onset of osteoarthritis, years (standard deviation)

7.1 (5.4)

7.4 (3.7)